RE:RE:RE:RE:RE:At least Marshall is still CEOThe health care side of things are progressing forward and providing some income and should continue to grow. Nexalagy has been tested and was able to move forward with the government testing programs. AGPT appears to be the biggest opportunity for substantial growth but the strategy to bring it to market needs different direction. Maybe this current downturn will give them the kick in the pants they need to smarten up on the marketing strategy. They will survive this but the turnaround timeframe will need to happen within the next quarter.